“difference was apparent”

When comparing treatment with phenobarbital alone to phenobarbital plus benzodiazepines, no statistically significant difference was apparent in the odds of a return ED visit within three days was found [AOR 1.7 (0.6, 5.2 p = 0.3)].

No reaction time difference was apparent between chronic TBI participants and healthy controls ( t (1 4 8) = -0.50, 95% CI [-0.18 – 0.11] , P = 0.309).

This gender difference was apparent in all individual ethnic groups and there was no strong evidence of an interaction between ethnic group and sex (p=0.33).

Unlike the GOLD classification, however, no significant difference was apparent among STAR stages for the frequency of individuals with a history of asthma ( P = 0.33 for heterogeneity).

No significant difference was apparent in perception of cancer cure between women who chose surveillance and those who chose surgery ( p =0.34).

The area under each curve was similar (0.91 for SF-LDQ vs 0.89 for SF-NDI), and no statistical difference was apparent between the two curves (p=0.35).

Though no statistically significant difference was apparent by gender ( p = 0.357) OIDP was more in males (68.3%) than females (31.7%).

Pairwise comparisons showed that SJOV had a significantly lower incidence of severe hypoxemia relative to the COT group ( P = 0.016), though no significant difference was apparent among COT and HFNC ( P = 0.362) or SJOV and HFNC ( P = 0.719).

At the three-month follow-up, no statistically significant between-group difference was apparent (MD=-1.3; 95% CI: -4.16 to 1.56; p=0.37; I2=34.96%).

Results With an OHIP-G14 sum score of 6.58 ± 6.40 [5; 2.5–8] in the HTx group and 5.54 ± 5.47 [5; 2–7] in the HF group, no clinically relevant or statistically significant difference was apparent ( p = 0.39).

Using paired t -tests, we found that for synesthetes, total fraction dominance was significantly larger for achromatic digits than for achromatic non-digits [ t (11) = 2.3, p = 0.04], whereas no such difference was apparent for controls [ t (11) = 0.8, p = 0.4].

However, no significant difference was apparent between the active treatment groups at study end (estimated difference for lumiracoxib versus celecoxib in APID: 2.0 mm, 95% CI -2.94 to +7.01 mm; P = 0.421).

No gender difference was apparent for television (p = 0.44) or lowPA time (p = 0.73).

When 2 groups were compared, the scores of Two-stage group were somewhat better than those of One-stage group at all times, but no significant difference was apparent ( P =0.458, 0.234, 0.772, 0.931).

This trend reflected more marble-burying in male binge-drinkers versus their water controls ( t (19) = 3.61, p = 0.002), while no alcohol-water difference was apparent in the females tested at this time ( t -test, p = 0.57). 3.4.

Clinically significant changes in pitch (ΔSFF ≥ 12) after surgery were evident in seven (15.91%) patients in the transoral group and eight (21.05%) patients in the open group; no significant between-group difference was apparent (p = 0.579) ( Figure 2 ). 4.

No significant difference was apparent between males and females ( P =0.58) ( Fig. 2A ).

More specifically, Tregs were identified as “CD4 + CD25 + ” cells [−0.884, (−1.201, −0.567), p ≤ 0.001], but no significant difference was apparent when Tregs were defined as “CD4 + CD25 high ” cells [−0.085, (−0.409, 0.238), p ≤ 0.606].

Surprisingly, no significant difference was apparent in any study [−0.113, (−0.552, 0.362), p = 0.613].

No significant difference was apparent between the IB and ZON groups ( p = 0.620, see Figure 2) .

Post-hoc tests showed that while GK rats took longer path lengths than Wistars on day 1 ( p = 0.04), by day 2 no significant difference was apparent ( p = 0.65).

However, no sex difference was apparent in the Δ ethanol intake ( Supplemental Table S9 , RM two-way ANOVA, sex: F (1, 20) = 0.1974, p = 0.6616, dose: F (1, 20) = 7.758, p = 0.0114, sex × dose: F (1, 20) = 0.2487, p = 0.6234, with Sidak’s MC (male vs female), p = 0.9993 for the Δ ethanol consumption following vehicle treatment, p = 0.7635 for the Δ ethanol consumption following 3 mg∙kg −1 7-hydroxyspeciogynine treatment).

49.4%, p = 0.001), although no notable difference was apparent at week 24(36.2% vs. 39.6%, p = 0.684) (Fig. 3 A).

Again, no significant difference was apparent (t (55) = -0.33, p = 0.746) ( Table 3 ).

However, no significant difference was apparent in the amplitude of the Ppc elicited by a stimulus presentation duration of 200 ms compared to 50 ms, t (29) = 0.252 , p = 0.803, Cohen’s d = 0.046 , BF 10 = 0.200 (two-tailed test) .